The importance of RSV F protein conformation in VLPs in stimulation of neutralizing antibody titers in mice previously infected with RSV
Respiratory syncytial virus (RSV) is a significant respiratory pathogen but no vaccine is available. RSV infections present 2 major, unique problems. First, humans can experience repeated infections caused by the same virus sero-group indicating that protective memory responses to RSV infection are...
Main Authors: | Lori M. Cullen, Madelyn R. Schmidt, Trudy G. Morrison |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2017.1329069 |
Similar Items
-
Comparison of Immune Responses to Different Versions of VLP Associated Stabilized RSV Pre-Fusion F Protein
by: Lori M. Cullen, et al.
Published: (2019-02-01) -
Current Insights in the Development of Efficacious Vaccines Against RSV
by: Jorge A. Soto, et al.
Published: (2020-07-01) -
Two RSV Platforms for G, F, or G+F Proteins VLPs
by: Binh Ha, et al.
Published: (2020-08-01) -
Epitope-Specific Serological Assays for RSV: Conformation Matters
by: Emily Phung, et al.
Published: (2019-02-01) -
Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
by: Dvir Gatt, et al.
Published: (2023-01-01)